Sage Therapeutics Inc. (NASDAQ:SAGE) went down by -0.78% during the previous trading session, and it is maintaining the win ahead of Thursday’s trading session. The share price of the Biotechnology giant went up by $43.01 to trade ended Thursday trading at $43.35. This is down from the $43.35 price recorded on Wednesday’s trading session. Thanks to this latest performance, SAGE is closer to the higher price 52-week target of $190.00 and further from the lowest price target of $35.00. Its performance from the start of the year has also been negative, with SAGE down by -40.42% year-to-date.
Sage Therapeutics Inc. (SAGE) started the day trading at $44.04 and recorded an intraday high of $44.8. It also recorded an intraday low of $42.92 during Thursday’s trading session. Sage Therapeutics Inc. is a very active stock that recorded a trading volume that is less than -77.1% of the average daily trading volume on Thursday. The stock’s trading volume on Thursday was 649337, which is less than -77.1 of the total average daily trading volume of 1.15 million.
Sage Therapeutics Inc. (NASDAQ:SAGE) 2020 Performance Impressive
The increase in SAGE’s stock price on Thursday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of SAGE currently stands at $193.56, which is higher than the current trading price of the stock by 77.78%. However, SAGE’s current trading price is -71.97% lower than the 52-week low price of $25.01. In terms of trading volume, Sage Therapeutics Inc. currently experienced healthy participation during the last trading session. 649337 shares of Sage Therapeutics Inc. were traded on the stock exchange on Thursday, which is less than -77.1% of the 1.15 million average trading volume of the stock.
The performance of the stock has been positive over the past year. SAGE’s performance over the past one year has seen it plunge by -76.17%, while the stock has gone down by -41.21% in the last six months. The quarterly performance of SAGE currently stands at 60.79%, and it is up by 19.47% in the last month. The only positive figure was from the weekly performance, which currently reads 1.68%. At the time of writing SAGE’s report, the company has a total market cap of $2.26B, making it one of the largest publicly-traded companies in the world.Sage Therapeutics Inc. also has over 675 employees all over the world.
SAGE Insider Activities
The insider transactions over the past six months are down by -128.80%.For Sage Therapeutics Inc. insiders bought 4,000 shares in 1 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Sage Therapeutics Inc. now hold 950.62k shares, which is over 109.71% of the total company stocks. Institutional investors currently hold a large chunk of the SAGE shares, as they control 1.83% of the company’s total stock.
SAGE Fundamental Analysis
For Sage Therapeutics Inc., the stock’s diluted earnings per share (EPS) stands at -12.46. In the coming year, analysts expect the EPS to be -9.19. The EPS growth will up over the next five years to 13.10% after plunging by -51.60% in the previous five years. In terms of revenue, Sage Therapeutics Inc.’s quarterly sales (YOY) is shrinking at -2.66, which is higher than the average annual revenue of -51.60% over the past half a decade.
The Return on Investment (ROI) on Sage Therapeutics Inc.’s stock currently stands at -75.00%. The gross margin of the company is 93.40%.
SAGE Analysts Prediction
Another analyst that has a Outperform rating for SAGE is RBC Capital Mkts, which set a price target of between $73 and $60. and H.C. Wainwright reiterate their Neutral position on the stock ($87 and $78).
Guggenheim and Jefferies also believe that Sage Therapeutics Inc.’s stock is outperforming at the moment. SAGE received a positive rating from RBC Capital Mkts, which set a price target of $190-$100 for the stock.
SAGE Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of SAGE currently stands at 9.63%, while the SMA50 is 12.02%. The biggest one is the SMA200, which is currently reading -43.94% ahead of Thursday’s trading session. The Relative Strength Index of this stock is 61.87.